TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
331,747
|
294,333
|
319,917 |
Financial expenses |
6
|
534
|
619 |
Earnings before taxes |
5,505
|
3,839
|
8,583 |
EBITDA |
7,114
|
7,134
|
12,224 |
Total assets |
137,560
|
114,721
|
125,920 |
Current assets |
126,132
|
102,307
|
109,870 |
Current liabilities |
86,340
|
64,105
|
76,553 |
Equity capital |
24,040
|
28,684
|
31,427 |
- share capital |
507
|
473
|
488 |
Employees (average) |
31
|
27
![]() |
27 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.5%
|
25.0%
![]() |
25.0% |
Turnover per employee |
10,702
|
10,901
|
11,849 |
Profit as a percentage of turnover |
1.7%
|
1.3%
|
2.7% |
Return on assets (ROA) |
4.0%
|
3.8%
|
7.3% |
Current ratio |
146.1%
|
159.6%
|
143.5% |
Return on equity (ROE) |
22.9%
|
13.4%
|
27.3% |
Change turnover |
16,529
|
-15,969
|
55,084 |
Change turnover % |
5%
|
-5%
|
21% |
Chg. No. of employees |
4
|
0
|
1 |
Chg. No. of employees % |
15%
|
0%
|
4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.